mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Bortezomib |
gCSI |
pan-cancer |
AAC |
0.074 |
0.2 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.2 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.065 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.2 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |